InnoStars Talks EIT Health InnoStars

Initial resistance from medical professionals towards AI has been overcome by working closely with doctors to develop technology they want to use. 

"Doctors should be using AI not only for a more precise diagnosis but for a more precise diagnosis 35 times an hour. That's the real secret,” Máté Balázs Kovács, co-founder and CEO of AIP Labs, tells me in the first episode of the InnoStars Talks series from EIT Health in partnership with Emerging Europe.  

AIP Labs describes itself as an artificial intelligence pioneer building the world's leading AI engines and infrastructure, including a proprietary Digital Hospital. It has built the first AI platform in the world to be integrated into the full social services for an entire country—Hungary—in collaboration with the most prestigious universities.   

AIP is extracting the full potential of the Hungarian clinical workforce by optimising operational efficiency through integrating and consolidating its existing infrastructure with the world's first Digital Hospital.  

In this episode, Balázs Fürjes invites to a chat with Professor Krzysztof Klincewicz from the Faculty of Management at Warsaw University.

The discussion, hosted by Andrew Wrobel focuses on the importance of collaborative innovation in boosting innovation in the European Union, particularly in countries with moderate or modest innovation scores.

Don't forget to visit our website at eithealth.eu/in-your-region/innostars/ for more information about our new programmes, calls for proposals and applications and events.

In this episode, Balázs Fürjes invites to a chat with Professor Guido Boella, Vice-Rector for Enterprises at the University of Turin. 

The discussion, hosted by Andrew Wrobel focuses on the role of digital innovation hubs in strengthening innovation in the European Union, particularly in countries with moderate or modest innovation scores.

Don't forget to visit our website at eithealth.eu/in-your-region/innostars/ for more information about our new programmes, calls for proposals and applications and events.

When the Covid-19 pandemic hit, health tech stepped up, with what appeared to be 10 years’ worth of innovation occurring in 10 weeks. But, while the pandemic encouraged more partnerships and collaboration in the sector, it has also brought about multiple challenges for start-ups, such as making it more difficult to complete clinical validation through sourcing hardware or delaying the implementation of their go-to-market strategies.

Tamás Békási, RIS Business Creation Manager at the EIT Health InnoStars, spoke with Andrew Wrobel about the current trends in health tech, opportunities and challenges, and offers plenty of advice to future healthcare hackers.

This year a total of 36 teams from all over Europe showcased their budding start-ups in front of a jury of experts and potential investors, competing for a prize pool of 160,000 euros. The flagship programme of the European Institute of Innovation and Technology (EIT), EIT Jumpstarter is a pre-accelerator programme led by EIT Health and involving other EIT Knowledge and Innovation Communities (KICs) with the goal of boosting innovation and entrepreneurship in Central, Eastern and Southern Europe.

In this episode, Balázs Fürjes speaks with Dora Marosvolgyi, EIT Jumpstarter mentor and project manager at EIT Health InnoStars, about the value the programme gives to your entrepreneurs and the innovation it creates.

Don't forget to visit our website at eithealth.eu/in-your-region/innostars/ for more information about our new programmes, calls for proposals and applications and events.

Success in precision medicine depends on accessing high-quality genetic and molecular data that, in conjunction with comprehensive clinical data, can lead to more effective therapies. Although omics data is available on public databases, doctors are not yet able to extract useful value from it owing to its sheer volume and heterogeneity.

While there are solutions to this problem - based on Big Data and Artificial Intelligence - these are mainly designed for specific diseases; this while there are 400 million patients around the globe affected by rare diseases. Kazaam Lab’s solution is an innovative, electronic, passive dosimeter based on a CMOS Floating Gate sensor monolithically implemented on a single chip.

Simona Rombo, an associate professor of computer science at the University of Palermo and one of the founders and the CEO of Kazaam Lab, spoke with Andrew Wrobel about the challenges her start-up has faced and overcome, as well as offering some tips for young researchers developing health solutions.